Impaired theta-gamma PAC has been demonstrated prior to Aβ accumulation in an amyloid mouse model AD [36] and in the tau-seeding model [24] and has been suggested to be a possible early functional biomarker of AD [63]. Here, MAPT is linked to Alzheimer disease.